icer glp-1 Weight-loss drugs becoming better value for money, says watchdog Bank of America: Novo Nordisk

GLP-1 agonists and tirzepatide may cause unpleasant side effects including dizziness, headache, indigestion or upset stomach, nausea, vomiting, diarrhoea and feeling jittery

GLP-1 receptors aren't just sitting in your gut regulating appetite

The GLP-1 Peptide FAQ on Meto's blog answers 15 of the most common pre-treatment questions in clinical detail a useful resource for anyone preparing for a prescriber conversation

With comprehensive medical supervision, nutritional guidance, and local accessibility for Nocatee families, our programs provide the results diet and exercise alone can't achieve

In a secondary analysis of REWIND, the incidence of non-fatal stroke was 2.7% in the dulaglutide group compared with 3.5% in the placebo group (HR = 0.76

This phase 3b trial evaluates mirikizumab combined with tirzepatide versus mirikizumab with a placebo in adult participants with moderately to severely active CD and comorbid obesity (111)